Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

An upcoming DCAT webinar this coming Tuesday Jan. 26, will provide thought leadership on what pharma companies, CDMOs/CMOs and other suppliers need to consider to further mitigate supply risk post COVID-19. The COVID-19 pandemic has placed new...

The latest on manufacturing, potential treatments, and testing for COVID-19 with news from Pfizer, AstraZeneca, Lilly, Sinovac, Grifols, and Abbott. Manufacturing and supply of COVID-19 vaccines and drugs Pfizer, BioNTech Provide Mfg, Delivery...

The European Commission (EC) is calling on its 27 member states to accelerate the rollout of COVID-19 vaccinations across the European Union (EU) with targets set for March 2021 and the summer of 2021.  In a communication document issued...

Sanofi has agreed to acquire Kymab, a Cambridge, UK-based biopharmaceutical company, in a $1.45-billion deal ($1.1 billion upfront and up to $350 million in milestones). Kymab’s lead product is KY1005, in Phase IIa development, for treating atopic...

Sanofi has chosen the name EUROAPI for its new European company dedicated to the development, production and marketing of active pharmaceutical ingredients (APIs). Sanofi announced the formation of the standalone company in February 2020. The new...

Novartis has signed a strategic collaboration agreement to in-license from BeiGene, a Beijing-based pharmaceutical company, in major markets outside of China, tislelizumab, a drug for treating classical Hodgkin’s lymphoma and metastatic urothelial...

As part of ongoing divestment program of non-core assets following its $62-billion acquisition of Shire in 2019, Takeda Pharmaceutical has moved forward with two additional divestment deals totaling a combined $844 million. In the first deal,...

Moderna, a clinical-stage biopharmaceutical company developing messenger RNA (mRNA) therapeutics and vaccines, reports that the European Commission (EC), Health Canada, the pharmaceutical regulatory body of Canada, and Israel’s Ministry of Health...